In pregnant women testing negative for HIV, second-trimester preexposure prophylaxis with the dapivirine vaginal ring or oral tenofovir disoproxil fumarate-emtricitabine is safe.

If the source person's HIV screening test result is negative but there has been a risk for HIV exposure in the previous 6 weeks, plasma HIV RNA testing of the source person is also recommended. In ...

"When newborns aren't getting preventive treatment, it suggests we may be missing HIV infections in pregnant women." HealthDay News — Although the rate of perinatal HIV infection is low, more than 50% ...

A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves ...

After launching a PrEP medication that was 100% effective in clinical trials, the company is facing a complex global rollout and leveraging its network of partners for help.

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

HealthDay News — Although the rate of perinatal HIV infection is low, more than 50% of HIV infections in infants before age 1 year occurred in those who did not receive postnatal prophylaxis, ...